Consumer Retailing Healthcare Sector

Cleo Diagnostics

Market Cap: AU$48.2m

A medical diagnostics and devices company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia.

Sona Nanotech

Market Cap: CA$42.8m

Operates as a nanotechnology life sciences company.

Enzo Biochem

Market Cap: US$30.9m

A life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally.

Tissue Regenix Group

Market Cap: UK£22.8m

A medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally.

Theralase Technologies

Market Cap: CA$42.3m

A clinical stage pharmaceutical company, engages in the research, development, and commercialization of light activated photo dynamic compounds and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally.

Concord Medical Services Holdings

Market Cap: US$30.5m

Through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China.

Revium Rx

Market Cap: US$30.4m

A pre-clinical stage biopharmaceutical company, develops nano-liposomal particles (NLP) based pharmaceutical candidates.

Angion Biomedica

Market Cap: US$30.1m

Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for chronic and progressive fibrotic diseases in the United States.

Vitura Health

Market Cap: AU$46.4m

Engages in the sale and distribution of medicinal cannabis products in Australia.

MariMed

Market Cap: US$30.0m

Engages in cultivation, production, and selling of branded cannabis products in the United States and internationally.

SCYNEXIS

Market Cap: US$30.0m

A biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States.

Light AI

Market Cap: CA$41.0m

A healthcare technology company, focuses on developing artificial intelligence health diagnostic solutions designed to differentiate between bacterial and viral infections at point-of-care facilities.

MTL Cannabis

Market Cap: CA$40.9m

Through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada.

Cadrenal Therapeutics

Market Cap: US$29.6m

Operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions.

Decibel Cannabis

Market Cap: CA$40.4m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

Island Pharmaceuticals

Market Cap: AU$45.2m

A drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections in Australia and the United States of America.

Cannabist Company Holdings

Market Cap: US$29.3m

The Cannabist Company Holdings Inc. cultivates, manufactures, and sells cannabis products and related services for the medical and adult-use markets in the United States and internationally.

CASI Pharmaceuticals

Market Cap: US$29.3m

A biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People’s Republic of China, the United States, and internationally.

Kezar Life Sciences

Market Cap: US$29.2m

A clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States.

NeuroOne Medical Technologies

Market Cap: US$29.2m

A medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States.

IntelGenx Technologies

Market Cap: US$29.2m

A drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market.

OnKure Therapeutics

Market Cap: US$28.9m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers.

Femasys

Market Cap: US$28.9m

A biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally.

Cynata Therapeutics

Market Cap: AU$44.1m

Engages in the development and commercialization of proprietary induced pluripotent stem cell and mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia.

Ayr Wellness

Market Cap: CA$39.0m

Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods.

PolyPid

Market Cap: US$28.4m

A clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs.

BlinkLab

Market Cap: AU$43.5m

Focuses on the development and commercialization of intellectual property related to smartphone-neurobehavioral testing.

MiNK Therapeutics

Market Cap: US$28.2m

A clinical-stage biopharmaceutical company, engages in the discovery, development, manufacture, and commercialization of allogeneic, off-the-shelf, and invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases.

Perimeter Medical Imaging AI

Market Cap: CA$38.3m

A medical technology company, provides advanced imaging solutions that address unmet medical needs.

Growth Stalk Holdings

Market Cap: US$27.4m

Engages in the sowing of the seeds for cultivation and selling of cannabis.

IDT Australia

Market Cap: AU$42.1m

Engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the Unites States.

Sareum Holdings

Market Cap: UK£20.2m

A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.

One Health Group

Market Cap: UK£20.1m

Provides diagnosis and treatment for orthopedics, spine, general surgery, and gynecology patients.

IGC Pharma

Market Cap: US$27.0m

A clinical stage pharmaceutical company, engages in developing treatments for Alzheimer’s disease.

International Isotopes

Market Cap: US$26.8m

Manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, sodium iodide I-131 drug product, and radiochemicals for clinical research and life sciences in the United States and internationally.

NeurAxis

Market Cap: US$26.5m

A medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.